Tumor cell stimulation via TLR8 activation has been demonstrated to bolster antitumor immunity through dual mechanisms: hindering senescence advancement in both senescent T cells and tumor-specific ones, thereby alleviating their immunosuppressive influence, both in vitro and in vivo242. Here, TLR8 is linked to neoplasm.